A detailed history of Atika Capital Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Atika Capital Management LLC holds 68,000 shares of NVO stock, worth $7.61 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares
68,000
Previous 100,500 32.34%
Holding current value
$7.61 Million
Previous $12.9 Million 24.78%
% of portfolio
1.15%
Previous 1.49%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$122.71 - $146.91 $3.99 Million - $4.77 Million
-32,500 Reduced 32.34%
68,000 $9.71 Million
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $10.3 Million - $13.7 Million
100,500 New
100,500 $12.9 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $7.59 Million - $16.7 Million
83,500 New
83,500 $7.59 Million
Q4 2022

Feb 13, 2023

BUY
$102.55 - $135.33 $1.91 Million - $2.52 Million
18,589 New
18,589 $2.52 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Atika Capital Management LLC Portfolio

Follow Atika Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atika Capital Management LLC with notifications on news.